In a phase 2 experiment, the Crohn’s disease medication developed by Ventyx Bios...
The Dutch government is on the verge of obtaining approval from the European Uni...
An experimental gene therapy from Pfizer performed well in a Phase 3 trial invol...
Brazil has restricted its exports of chicken meat and eggs to 44 nations after t...
Ionis Pharmaceuticals is set to advance one of its drugs for Angelman syndrome t...
Pinetree Therapeutics, a biotechnology firm focused on developing targeted prote...
Merck & Co. hope to become the latest company to gain approval for a drug to ave...
Scorpion Therapeutics has raised $150M to strengthen its clinical pipeline by ad...
The FDA has been instructed by lawmakers to halt the implementation of its final...
Sionna Therapeutics has swiftly found a way to put part of its $182 million seri...
With the acquisition of Meilleur Technologies, Lantheus is expanding its portfol...
Research findings from new studies show that organ damage resulting from Covid-1...
Alzheimer’s drugs have been flooding the market lately, as investors look for th...
Three patients with autoimmune disorders have responded favorably to allogeneic ...
Antibiotic-drug conjugates (ADCs) are a highly competitive biologics segment. Th...
Beacon Therapeutics has secured $170 million in Series B funding, which the gene...
